Development of a new, more sensitive immunoassay for human tryptase: Use in systemic anaphylaxis
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Tryptase, a neutral protease, is selectively concentrated in the secretory granules of human mast cells, and its release into the circulation serves as a clinical marker of mast cell activation. The current study describes a new, more sensitive ELISA utilizing a newly developed, mouse monoclonal IgG1 antibody for capture called B12 and capable of detecting tryptase in normal plasma and serum. The greater sensitivity of the new immunoassay results in part from a greater portion of tryptase being detected. Mean levels of tryptase in serum from normal subjects from Richmond, Virginia (4.9 ng/ml; n = 56), Munich, Germany (3.8 ng/ml; n = 19), and Amersfoort, The Netherlands (1.9 ng/ml; n = 8) were as indicated. In 62 subjects with ongoing allergic rhinitis, tryptase levels were no different in serum than for 19 normal controls, indicating that local mast cell activation is not necessarily reflected in the circulation. In 61 subjects sensitive to honey bee or yellow jacket venom by history, the 17 destined to have a severe, hypotensive response to a sting challenge had higher levels of tryptase at baseline than mild reactors, nonreactors, and controls, suggesting that baseline levels of tryptase may predict the severity of the clinical response to allergen in sensitive subjects.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“The tryptase assay commercially available from Thermo Fisher® (Waltham, MA, USA) ImmunoCAP measures all of these isoforms in monomeric and tetrameric form (i.e., total serum tryptase) [9].”
From Diagnostic Significance of Tryptase for Suspected Mast Cell Disorders (2023) · cites this paper as [9]
In the citing paper
“peaks in serum about 1 hour after clinical onset of the event”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [40]
In the citing paper
“and may remain elevated 4 hours or longer, depending on the magnitude of the initial elevation.”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [40]
In the citing paper
“and then declines with a half-life of about 2 hours”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [40]
In the citing paper
“The tryptase level usually increases during substantial systemic MCA/ degranulation”
From Selecting the Right Criteria and Proper Classification to Diagnose Mast Cell Activation Syndromes: A Critical Review (2021) · cites this paper as [40]
Citations
Cites
Fatal and Near-Fatal Anaphylactic Reactions to Food in Children and Adolescents
Sampson, H. A., Mendelson, L., & Rosen, J. P. (1992) · New England Journal of Medicine · doi:10.1056/nejm199208063270603 · Cited by 1,609 · cited 1×
“Clinically similar presentations of anaphylaxis have been reported, some of which exhibit elevated levels of tryptase (1, 5-13), as expected if mast cells are involved, whereas other forms, particularly some instances of food-induced anaphylaxis ( 14 ), show no elevation, suggesting a mechanism that does not involve m…”
Two types of human mast cells that have distinct neutral protease compositions.
Irani, A. A., Schechter, N. M., Craig, S. S., DeBlois, G., & Schwartz, L. B. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.12.4464 · Cited by 1,005
Self-citationTryptase levels as an indicator of mast-cell activation in systemic anaphylaxis and mastocytosis
Schwartz, L. B., Metcalfe, D. D., Miller, J. S., Earl, H., & Sullivan, T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198706253162603 · Cited by 784 · cited 2×
“anaphylaxis and systemic mastocytosis (1).”
Self-citationSchwartz, L. B., Yunginger, J. W., Miller, J., Bokhari, R., & Dull, D. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114051 · Cited by 456 · cited 1×
“some of which exhibit elevated levels of t ryptase (1, 5-13), as expected if mast cells are involved,”
Self-citationIrani, A. M., Bradford, T. R., Kepley, C. L., Schechter, N. M., & Schwartz, L. B. (1989) · Journal of Histochemistry & Cytochemistry · doi:10.1177/37.10.2674273 · Cited by 404
Self-citationWenzel, S. E., Fowler, A. A., & Schwartz, L. B. (1988) · American Review of Respiratory Disease · doi:10.1164/ajrccm/137.5.1002 · Cited by 351
Self-citationRegulation of tryptase from human lung mast cells by heparin. Stabilization of the active tetramer.
Schwartz, L. B., & Bradford, T. R. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38401-6 · Cited by 348
Self-citationEvidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway
Broide, D. H., Gleich, G. J., Cuomo, A. J., Coburn, D. A., Federman, E. C., Schwarte, L. B., & Wasserman, S. I. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90158-k · Cited by 282
Evaluation of human peripheral blood leukocytes for mast cell tryptase
Castells, M. C., Irani, A. M., & Schwartz, L. B. (1987) · The Journal of Immunology · doi:10.4049/jimmunol.138.7.2184 · Cited by 278
Self-citationSedgwick, J. B., Calhoun, W. J., Gleich, G. J., Kita, H., Abrams, J. S., Schwartz, L. B., Volovitz, B., Ben-Yaakov, M., & Busse, W. W. (1991) · American Review of Respiratory Disease · doi:10.1164/ajrccm/144.6.1274 · Cited by 275
Self-citation
Research works printed but not linked: 1
- Schwartz LB, Huff TF: Biology of mast cells and basophils.In Allergy: Principals and Practice, E Middleton, Jr., CE Reed, EF Ellis, NF Adkinson, Jr., JW Yunginger, WW Busse (eds). St. Louis, Mosby-Year Book, 1993, pp 135?168
Cited by
WENZEL, S. E., SCHWARTZ, L. B., LANGMACK, E. L., HALLIDAY, J. L., TRUDEAU, J. B., GIBBS, R. L., & CHU, H. W. (1999) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.160.3.9812110 · Cited by 1,235
Self-citationDiagnostic criteria and classification of mastocytosis: a consensus proposal
Valent, P., Horny, H.-P., Escribano, L., Longley, B. J., Li, C. Y., Schwartz, L. B., Marone, G., Nuñez, R., Akin, C., Sotlar, K., et al. (2001) · Leukemia Research · doi:10.1016/s0145-2126(01)00038-8 · Cited by 1,108
Self-citationValent, P., Akin, C., Escribano, L., Födinger, M., Hartmann, K., Brockow, K., Castells, M., Sperr, W. R., Kluin‐Nelemans, H. C., Hamdy, N. A. T., et al. (2007) · European Journal of Clinical Investigation · doi:10.1111/j.1365-2362.2007.01807.x · Cited by 750
Self-citationValent, P., Akin, C., Arock, M., Brockow, K., Butterfield, J. H., Carter, M. C., Castells, M., Escribano, L., Hartmann, K., Lieberman, P., et al. (2012) · International Archives of Allergy and Immunology · doi:10.1159/000328760 · Cited by 654
Self-citationDiagnosis of immediate allergic reactions to beta‐lactam antibiotics
Torres, M. J., Blanca, M., Fernandez, J., Romano, A., de Weck, A., Aberer, W., Brockow, K., Pichler, W. J., Demoly, P., for, E. N. D. A., et al. (2003) · Allergy · doi:10.1034/j.1398-9995.2003.00280.x · Cited by 522
Metadata
- Authors
- Schwartz, L. B., Bradford, T. R., Rouse, C., Irani, A.-M., Rasp, G., Van Der Zwan, J. K., & Van Der Linden, P.-W. G.
- Affiliations
- Virginia Commonwealth University (US)
- Ludwig-Maximilians-Universität München (DE)
- ORCID
- Rasp, Gerd
- Venue
- Journal of Clinical Immunology
- Published
- 1994-05
- Volume
- 14
- Issue
- 3
- Pages
- 190-204
- ISSN
- 0271-9142 (ISSN-L)
- 1573-2592
- OpenAlex
- W2008921144
- Cited by
- 263
- References
- 46
- Citations by year
- 2026: 1 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 8 · 2021: 8 · 2020: 2 · 2019: 6 · 2018: 7 · 2017: 9 · 2016: 6 · 2015: 5 · 2014: 5 · 2013: 15 · 2012: 8
- FWCI
- 1.67
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Journal of Clinical Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (AI20487, AI-01076)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Mast cells and histamine
- Health Sciences › Medicine › Immunology and Allergy › Food Allergy and Anaphylaxis Research
- Health Sciences › Medicine › Immunology and Allergy › Allergic Rhinitis and Sensitization
- Keywords
- tryptase, immunoassay, ELISA, mast cell activation, systemic anaphylaxis, allergic rhinitis, venom allergy, honey bee venom, yellow jacket venom, sting challenge, monoclonal antibodies
- MeSH terms
- Anaphylaxis, Animals, Antibodies, Monoclonal, Bee Venoms, Enzyme-Linked Immunosorbent Assay, Female, Rhinitis, Allergic, Seasonal, Humans, Hypersensitivity, Immediate, Mice, Inbred BALB C, Serine Endopeptidases, Wasp Venoms, Mice, Tryptases, Chymases
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.